Paul Mampily |
|||
| No | Stocks | Description | Thesis |
| 1 | Foundation Medicine | Notes in 26 September 2017. Foundation Medicine, Inc. is an American company based in Cambridge, Massachusetts which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas. | Roche will acquire the remainder of Foundation Medicine for $2.4 billion in cash, the companies said today. |
| 2 | Codexis | Codexis, Inc. is a leading protein engineering company that applies its CodeEvolver platform technology to create high-performing enzymes for improving the cost and quality of pharmaceuticals and food ingredients, to enable sequencing of minute quantities of DNA for medical diagnostics, and to create novel biotherapeutics. | Using the latest and greatest artificial intelligence (AI) technology, Codexis’ platform tests different combinations of amino acids to see if they may fit into the needed chemical reaction.. |
| 3 | Myriad Genetics Inc. | Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. | Precision medicine is going to revolutionize the $1.7 trillion health care industry, and Myriad Genetics stands at the forefront of that revolution with its offering of tests to identify diseases and potential markers within your genetic code.. |